Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04645693 · ClinicalTrials.gov registry record
The Impact of Oral Health in HIV Patients on Antiretroviral Therapy
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 227
- Enrollment target
NCT04645693: Completed study, sponsored by University of Pennsylvania.
NCT04645693 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 227 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04645693 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 227 participants
- Enrollment target
Study Summary
This is a prospective cohort study designed to investigate the range of metabolic abnormalities observed in patients living with HIV on antiretroviral therapy. This study will also explore the concurrent role of poor oral health in supporting and driving chronic immune activation and inflammation in HIV infection.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 227 participants |
| Start Date | 2021-02-24 |
| Est. Completion | 2026-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04645693
The ClinicalTrials.gov registry entry for NCT04645693 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 227 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04645693 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04645693 about?
NCT04645693 is a clinical study titled "The Impact of Oral Health in HIV Patients on Antiretroviral Therapy". This is a prospective cohort study designed to investigate the range of metabolic abnormalities observed in patients living with HIV on antiretroviral therapy. This study will also explore the concurrent role of poor oral health in supporting and driving chronic immune activation and inflammation in...
What is the current status of trial NCT04645693?
This trial is currently completed. The enrollment target is 227 participants. The study started on 2021-02-24. Estimated completion is 2026-02-28.
Who is sponsoring clinical trial NCT04645693?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.